相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vancomycin-resistant staphylococcus aureus in the United States, 2002-2006
Dawn M. Sievert et al.
CLINICAL INFECTIOUS DISEASES (2008)
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia
Pamela A. Moise et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S-aureus (MRSA) blood isolates from 2001-05
Gregory Steinkraus et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia
Pamela A. Moise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF
Satish K. Pillai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Community- and health care-associated methicillin-resistant Staphylococcus aureus:: a comparison of molecular epidemiology and antimicrobial activities of various agents
Brian T. Tsuji et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus
Brian T. Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid
Seok-Ming Toh et al.
MOLECULAR MICROBIOLOGY (2007)
High-level vancomycin-resistant staphylococcus aureus isolates associated with a polymicrobial biofilm
Linda M. Weigel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period
Guiqing Wang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia -: Specific evaluation of vancomycin pharmacokinetic indices
Meghan N. Jeffres et al.
CHEST (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Methicillin-resistant S-aureus infections among patients in the emergency department
Gregory J. Moran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Epidemiological profile of linezolid-resistant coagulase-negative staphylococci
Brian A. Potoski et al.
CLINICAL INFECTIOUS DISEASES (2006)
Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus
L Friedman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia
G Sakoulas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria:: FAST 2 study
ME Stryjewski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus Bacteremia
David Hirschwerk et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The pharmacokinetic and pharmacodynamic properties of vancomycin
MJ Rybak
CLINICAL INFECTIOUS DISEASES (2006)
Microbiological features of vancomycin in the 21st century: Minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains
RN Jones
CLINICAL INFECTIOUS DISEASES (2006)
Vancomycin resistance in gram-positive cocci
P Courvalin
CLINICAL INFECTIOUS DISEASES (2006)
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus
JB Patel et al.
CLINICAL INFECTIOUS DISEASES (2006)
Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus
MK Hayden et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
The burden of Staphylococcus aureus infections on hospitals in the United States -: An analysis of the 2000 and 2001 nationwide inpatient sample database
GA Noskin et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
J Weigelt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital:: Quantitative testing redux
KY Rhee et al.
CLINICAL INFECTIOUS DISEASES (2005)
Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus
JN Sharpe et al.
AMERICAN JOURNAL OF SURGERY (2005)
Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia
A Mangili et al.
CLINICAL INFECTIOUS DISEASES (2005)
High prevalence of methicillinresistant Staphylococcus aureus in emergency department skin and soft tissue infections
BW Frazee et al.
ANNALS OF EMERGENCY MEDICINE (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure
CJ Whitener et al.
CLINICAL INFECTIOUS DISEASES (2004)
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility
BP Howden et al.
CLINICAL INFECTIOUS DISEASES (2004)
Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA
VG Meka et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Linezolid eradicates MRSA better than vancomycin from surgical-site infections
J Weigelt et al.
AMERICAN JOURNAL OF SURGERY (2004)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
D Cardo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2004)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Drotrecogin alfa (activated) improves in-hospital and 90-day survival in patients with severe sepsis and community-acquired pneumonia
RG Wunderink et al.
CHEST (2003)
Staphylococcus aureus with heterogeneous resistance to vancomycin:: Epidemiology, clinical significance, and critical assessment of diagnostic methods
C Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin
A Reipert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus
K Sieradzki et al.
JOURNAL OF BACTERIOLOGY (2003)
Linezolid vs vancomycin - Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia
RG Wunderink et al.
CHEST (2003)
Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis
SH Marshall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Linezolid resistance in a clinical isolate of Staphylococcus aureus
S Tsiodras et al.
LANCET (2001)
分享论文
